SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-715629
Filing Date
2016-09-21
Accepted
2016-09-21 11:05:03
Documents
8
Period of Report
2016-10-21
Effectiveness Date
2016-09-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d256976ddef14a.htm DEF 14A 212805
2 GRAPHIC g256976g27o48.jpg GRAPHIC 252537
3 GRAPHIC g256976img02.jpg GRAPHIC 142589
4 GRAPHIC g256976stp006a.jpg GRAPHIC 9962
5 GRAPHIC g256976stp006b.jpg GRAPHIC 7972
6 GRAPHIC g256976txpg004a.jpg GRAPHIC 1716
7 GRAPHIC g256976txpg004b.jpg GRAPHIC 1043
8 GRAPHIC g256976txpg004c.jpg GRAPHIC 1266
  Complete submission text file 0001193125-16-715629.txt   789663
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 161895137
SIC: 2834 Pharmaceutical Preparations